Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease.

Lougaris V, Moratto D, Baronio M, Tampella G, van der Meer JW, Badolato R, Fliegauf M, Plebani A.

J Allergy Clin Immunol. 2016 Jul 16. pii: S0091-6749(16)30628-5. doi: 10.1016/j.jaci.2016.05.045. [Epub ahead of print] No abstract available.

PMID:
27555455
2.

Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation.

Tripodi SI, Mazza C, Moratto D, Ramenghi U, Caorsi R, Gattorno M, Badolato R.

Immunol Lett. 2016 Sep;177:22-4. doi: 10.1016/j.imlet.2016.07.001. Epub 2016 Jul 1.

PMID:
27378136
3.

Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency.

Prandini A, Salvi V, Colombo F, Moratto D, Lorenzi L, Vermi W, De Francesco MA, Notarangelo LD, Porta F, Plebani A, Facchetti F, Sozzani S, Badolato R.

Blood. 2016 Jun 30;127(26):3382-6. doi: 10.1182/blood-2015-06-650689. Epub 2016 May 13.

PMID:
27207797
4.

Clinical and immunological data of nine patients with chronic mucocutaneous candidiasis disease.

Dotta L, Scomodon O, Padoan R, Timpano S, Plebani A, Soresina A, Lougaris V, Concolino D, Nicoletti A, Giardino G, Licari A, Marseglia G, Pignata C, Tamassia N, Facchetti F, Vairo D, Badolato R.

Data Brief. 2016 Feb 23;7:311-5. doi: 10.1016/j.dib.2016.02.040. eCollection 2016 Jun.

5.

Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions.

Giacomelli M, Kumar R, Soresina A, Tamassia N, Lorenzini T, Moratto D, Gasperini S, Cassatella M, Plebani A, Lougaris V, Badolato R.

J Allergy Clin Immunol. 2016 Jul;138(1):229-240.e3. doi: 10.1016/j.jaci.2015.10.051. Epub 2016 Feb 11.

PMID:
26875746
6.

Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease.

Dotta L, Scomodon O, Padoan R, Timpano S, Plebani A, Soresina A, Lougaris V, Concolino D, Nicoletti A, Giardino G, Licari A, Marseglia G, Pignata C, Tamassia N, Facchetti F, Vairo D, Badolato R.

Clin Immunol. 2016 Mar;164:1-9. doi: 10.1016/j.clim.2015.12.010. Epub 2015 Dec 28.

PMID:
26732859
7.

Novel STAT1 gain-of-function mutation and suppurative infections.

Giardino G, Somma D, Cirillo E, Ruggiero G, Terrazzano G, Rubino V, Ursini MV, Vairo D, Badolato R, Carsetti R, Leonardi A, Puel A, Pignata C.

Pediatr Allergy Immunol. 2016 Mar;27(2):220-3. doi: 10.1111/pai.12496. Epub 2015 Dec 15. No abstract available.

PMID:
26467763
8.

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.

PMID:
26322666
9.

Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.

Taddio A, Tommasini A, Valencic E, Biagi E, Decorti G, De Iudicibus S, Cuzzoni E, Gaipa G, Badolato R, Prandini A, Biondi A, Ventura A.

World J Gastroenterol. 2015 Apr 14;21(14):4379-84. doi: 10.3748/wjg.v21.i14.4379.

10.

Interferon-α production by plasmacytoid dendritic cells is dispensable for an effective anti-cytomegalovirus response in adaptor protein-3-deficient mice.

Del Prete A, Luganini A, Scutera S, Rossi S, Anselmo A, Greco D, Landolfo S, Badolato R, Gribaudo G, Sozzani S, Musso T.

J Interferon Cytokine Res. 2015 Mar;35(3):232-8. doi: 10.1089/jir.2013.0110. Epub 2014 Oct 21.

11.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

12.

Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation.

Lougaris V, Vitali M, Baronio M, Moratto D, Tampella G, Biasini A, Badolato R, Plebani A.

J Clin Immunol. 2014 May;34(4):425-7. doi: 10.1007/s10875-014-0033-4. Epub 2014 Apr 11.

PMID:
24722855
13.

Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients.

Caracciolo S, Moratto D, Giacomelli M, Negri S, Lougaris V, Porta F, Pajno G, Salpietro A, Montin D, Dinwiddie DL, Kingsmore SF, Plebani A, Badolato R.

Clin Immunol. 2014 May-Jun;152(1-2):164-70. doi: 10.1016/j.clim.2014.03.008. Epub 2014 Mar 24.

PMID:
24674883
14.

Clinical features and follow-up in patients with 22q11.2 deletion syndrome.

Cancrini C, Puliafito P, Digilio MC, Soresina A, Martino S, Rondelli R, Consolini R, Ruga EM, Cardinale F, Finocchi A, Romiti ML, Martire B, Bacchetta R, Albano V, Carotti A, Specchia F, Montin D, Cirillo E, Cocchi G, Trizzino A, Bossi G, Milanesi O, Azzari C, Corsello G, Pignata C, Aiuti A, Pietrogrande MC, Marino B, Ugazio AG, Plebani A, Rossi P; Italian Network for Primary Immunodeficiencies.

J Pediatr. 2014 Jun;164(6):1475-80.e2. doi: 10.1016/j.jpeds.2014.01.056. Epub 2014 Mar 20.

PMID:
24657119
15.

Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation.

Lougaris V, Baronio M, Vitali M, Tampella G, Cattalini M, Tassone L, Soresina A, Badolato R, Plebani A.

J Allergy Clin Immunol. 2014 Jun;133(6):1644-50.e4. doi: 10.1016/j.jaci.2013.12.1085. Epub 2014 Mar 4.

PMID:
24612681
16.

α- and β-papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions.

Landini MM, Borgogna C, Peretti A, Colombo E, Zavattaro E, Boldorini R, Miglio U, Doorbar J, Ravanini P, Kumar R, Moratto D, Badolato R, De Andrea M, Gariglio M.

J Am Acad Dermatol. 2014 Jul;71(1):108-15.e1. doi: 10.1016/j.jaad.2014.01.859. Epub 2014 Mar 4.

PMID:
24612648
17.

Primary immunodeficiences--options for the future.

Badolato R.

Pediatr Allergy Immunol. 2014 Feb;25(1):27-9. doi: 10.1111/pai.12192. No abstract available.

PMID:
24588485
18.

Activin A as a mediator of NK-dendritic cell functional interactions.

Seeger P, Bosisio D, Parolini S, Badolato R, Gismondi A, Santoni A, Sozzani S.

J Immunol. 2014 Feb 1;192(3):1241-8. doi: 10.4049/jimmunol.1301487. Epub 2014 Jan 6.

19.

Primary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia.

Dotta L, Badolato R.

Immunol Lett. 2014 Oct;161(2):222-5. doi: 10.1016/j.imlet.2013.11.018. Epub 2013 Dec 4. Review.

PMID:
24316408
20.

Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.

Lorenzi L, Tabellini G, Vermi W, Moratto D, Porta F, Notarangelo LD, Patrizi O, Sozzani S, de Saint Basile G, Latour S, Pace D, Lonardi S, Facchetti F, Badolato R, Parolini S.

PLoS One. 2013 Nov 26;8(11):e80131. doi: 10.1371/journal.pone.0080131. eCollection 2013.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk